{"id":239,"date":"2023-11-23T00:02:00","date_gmt":"2023-11-23T00:02:00","guid":{"rendered":"http:\/\/worldscientists.fr\/?p=239"},"modified":"2024-03-27T23:26:29","modified_gmt":"2024-03-27T23:26:29","slug":"the-invention-ifibr-fibranium-analysis-of-efficacy-and-indications-for-use","status":"publish","type":"post","link":"http:\/\/worldscientists.fr\/?p=239","title":{"rendered":"THE INVENTION \u201cIFIBR \u2013 FIBRANIUM\u201d. ANALYSIS OF EFFICACY AND INDICATIONS FOR USE"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Dr. Lorusso Rossi Alessandro, PhD (Reading) , (IUHAC Paris, California University USA)<\/p>\n\n\n\n

Keywords<\/strong>: chronic low back pain, placebo-control, randomised clinical trial, natural minerals, siliconised fibre, nanotechnology, silica, anti-ageing therapy.<\/p>\n\n\n\n

 The invention \u2013 ionnovation mattress pad \u201cIFIBR \u2013 FIBRANIUM\u201d \u2013 is a product, the use of which promotes rapid relief of chronic lumbar pain, restoration of the nervous system, normalisation of sleep, relief of neuropsychic tension. The product contributes to the normalisation of energy-information processes in the body and can be successfully used as an element of anti-ageing programmes.<\/p>\n\n\n\n

 This article is devoted to the principles that formed the basis of a breakthrough nanotechnological invention \u2013 the innovative mattress pad \u201cIFIBR \u2013 FIBRANIUM \u201c.<\/p>\n\n\n\n

Chronic pain syndromes of lumbosacral localisation have received a lot of attention in scientific literature. The relevance of the problem is determined not only by medical, but also by social factors. It is known that in 10-20% of patients of working age acute back pain is transformed into chronic pain. This group of patients is characterised by an unfavourable prognosis for recovery and accounts for up to 80% of all health care costs for back pain treatment. According to the criteria of the International Association for the Study of Pain, chronic pain is pain that persists beyond the normal healing period. There have been repeated attempts to identify risk factors for the development of chronic pain and disability. Based on the analysis of prospective studies, medical, ergonomic, psychosocial, and socio-demographic factors of chronic disability associated with lumbosacral pain have been identified. These include: irradiation of pain to the leg combined with a positive Laseg\u2019s symptom; previous episodes of pain in the lumbar region that required seeking medical help; psychosocial aspects of work, especially the patient\u2019s perceptions of the difficulty of the job and his or her own ability to cope with it; the patient\u2019s belief that low back pain is related to working conditions; negative opinions about the prognosis of the disease; and the desire for financial compensation. Gender, age, ethnicity, and education level were not associated with chronic disability due to lumbosacral pain.<\/p>\n\n\n\n

The most common causes of lumbar pain are spinal diseases, primarily degenerative-dystrophic (osteochondrosis, deforming spondylosis), and overstretching of the back muscles. In addition, various diseases of the abdominal cavity and pelvic organs, including tumours, can cause the same symptoms as a herniated disc, compressing the spinal root.<\/p>\n\n\n\n

It is not by chance that such patients turn not only to neurologists, but also to gynaecologists, orthopaedists, urologists, and above all, of course, to district or family doctors.<\/p>\n\n\n\n

Risk factors for lumbar pain are:<\/p>\n\n\n\n

\u2013 heavy physical exertion;<\/p>\n\n\n\n

\u2013 uncomfortable working posture;<\/p>\n\n\n\n

\u2013 trauma;<\/p>\n\n\n\n

\u2013 cold, draughts;<\/p>\n\n\n\n

\u2013 alcohol abuse;<\/p>\n\n\n\n

\u2013 depression and stress;<\/p>\n\n\n\n

\u2013 occupational diseases associated with exposure to high temperatures (in particular, in hot shops), radiant energy, sharp temperature fluctuations, vibration.<\/p>\n\n\n\n

Among the vertebral causes of lumbar pain distinguish:<\/p>\n\n\n\n

\u2013 radicular ischaemia (discogenic radicular syndrome, discogenic radiculopathy) resulting from compression of the radicle by a herniated disc;<\/p>\n\n\n\n

\u2013 reflex muscle syndromes, which may be caused by degenerative-dystrophic changes in the spine.<\/p>\n\n\n\n

Chronic lumbar pain, both local regional and widespread, does not belong to a single nosological form. It is a universal and typical pathological process characteristic of various diseases of the nervous system, pathology of the musculoskeletal system and internal organs. It is based on a trigger point arising under the influence of a pathological contractile mechanism.<\/p>\n\n\n\n

In the pathogenesis of IFIBR, great importance is also attached to the peculiarities of functioning of various CNS departments, which carry out motor and sensory organisation of motor acts, as well as emotional and affective support of the organism\u2019s activity<\/p>\n\n\n\n

The product \u201cIFIBR \u2013 FIBRANIUM \u201d is a cotton mat with 30% content of silica fibres, the source of which is a healing earth mined in South Korea, now known as FIBRILIUM, containing a special type of silicon crystals. The hollow siliconised fibre is comparable to natural down in its airiness, comfort and elasticity, therefore the mattress cover from the manufacturer \u201cElox\u201d GmbH, Austria creates ideal conditions for a healthy sleep.<\/p>\n\n\n\n

FIBRANIUM fibre is capable of restoring the flow of energy in the body. It has its own radiation, thus stabilising the body\u2019s energy balance.<\/p>\n\n\n\n

FIBRANIUM fibres, together with natural minerals, are used as a filler in a mat (lyocell \/ 100% wool), which is then used as a cover for an ordinary sleeping mattress, on which you can sleep at night. The hypothesis that this fabric reflects infrared and near-infrared body radiation (wavelength 4-14 nm) was confirmed by an in-depth laboratory study.<\/p>\n\n\n\n

In addition to the idea of using FIBRANIUM fibres, the development of \u201cIFIBR \u2013 fibranium\u201d is based on the theory of the therapeutic effect on the human body of groups of natural minerals, i.e. natural chemical compounds and their mechanical mixtures, which have high biogenicity, or the ability to ensure interaction between biosubstrates in the implementation of metabolic reactions at the cellular, organ and system level. Their origin is the Western spurs of the highest mountain systems of the planet Earth, the Himalayas.<\/p>\n\n\n\n

Among the mineral salts dispersed in the lithosphere, which were subject to clinical and pharmacological study in this study, the most valuable are: native silver with an admixture of gold; the family of platinum metals (platinum and its permanent companions: iridium, osmium, palladium, ruthenium, radium); beryl and its varieties \u2013 aquamarine and emerald; corundum with an admixture of chromium \u2013 ruby, with an admixture of iron and titanium \u2013 sapphire; halogens (bromine, fluorine, chromium, iodine); chalcogenes (sulphur, selenium); alkali (lithium, sodium, potassium) and alkaline-earth metals (magnesium, calcium, barium, beryllium); iron family.<\/p>\n\n\n\n

The technology applied in the manufacture of the product \u201cIFIBR \u2013 fibranium\u201d meets the requirements of novelty and is used to realise the potential of artificially unreproducible natural minerals.<\/p>\n\n\n\n

The application of technology with the use of FIBRANIUM fibres in combination of silicon crystals with groups of natural minerals allowed to achieve a significant increase and expansion of therapeutic, preventive and consumer properties of the product \u201cIFIBR \u2013 fibranium\u201d.<\/p>\n\n\n\n

 Practical significance of the invention<\/strong><\/p>\n\n\n\n

Lower back pain (low back pain, shooting pain, a feeling of aching or pulling in the lumbar region) is a common complaint of patients when visiting a doctor. According to international medical statistics, at least 70 per cent of the population experience such symptoms at least once in their lifetime. In 10 per cent of cases, low back pain attacks become chronic.<\/p>\n\n\n\n

If the pain lasts up to 4 weeks, it is called acute, from 4 to 12 weeks \u2013 subacute, over 12 weeks \u2013 chronic.<\/p>\n\n\n\n

The most common causes of lumbar pain (90 to 95%) are disorders of the musculoskeletal apparatus of the back. Such pain is called lumbalgia. In this form, the source of pain can be localised in the area of:<\/p>\n\n\n\n

\u2013 muscles and ligaments of the back (myofascial pain syndrome),<\/p>\n\n\n\n

\u2013 the joints of the vertebrae (facet syndrome),<\/p>\n\n\n\n

\u2013 the sacroiliac joint,<\/p>\n\n\n\n

\u2013 intervertebral discs (intervertebral disc protrusion, extrusion).<\/p>\n\n\n\n

The structure of symptomatology is as follows:<\/strong><\/p>\n\n\n\n

 80-85 % \u2013 non-specific low back pain. Symptomatology subsides within a few weeks;<\/p>\n\n\n\n

10-15% \u2013 spinal stenosis, radiculopathy causing nerve root compression;<\/p>\n\n\n\n

1-2% \u2013 a specific syndrome caused by oncopathology, diseases of internal organs.<\/p>\n\n\n\n

Low back pain ranks second in duration and third in frequency of causes of temporary disability among all diseases. Low back pain is one of the most significant medical problems worldwide and is difficult to treat.<\/p>\n\n\n\n

It is the solution to the problem of chronic lumbar pain caused by disorders of the musculoskeletal apparatus of the back that has been the focus of many years of scientific research and randomised clinical trials conducted by specialists from Elox GmbH, Austria.<\/p>\n\n\n\n

Confirmation of the efficacy of the invention<\/strong><\/p>\n\n\n\n

In order to test and confirm the efficacy of the IFIBR-fibranium product for the claimed purposes, three parallel blind and placebo-controlled randomised studies in patients with chronic low back pain, premenstrual syndrome and arthralgic pain, 50 patients in each study (150 patients in each study) were conducted in accordance with the GCP and in compliance with the Declaration of Helsinki. The study was submitted and approved by the ethics committee in Carinthia with registration number: A35\/16.<\/p>\n\n\n\n

The study confirmed a very strong clinical effect in this strictly blind and placebo-controlled study over 4 weeks in patients with chronic low back pain.<\/p>\n\n\n\n

In addition, the IFIBR \u2013 fibranium products were submitted to the Research laboratory of integrative medicine of the International University of Fundamental Learning for independent expertise and preparation for further certification, St. Petersburg, Russia, INTER-UNIVERSIT\u00c9 CONSEIL ACAD\u00c9MIQUE SUP\u00c9RIEUR, Paris, France and TARPTAUTINIS FUNDAMENTALI\u0172 STUDIJ\u0172 UNIVERSITETAS, Vilnius, Lithuania.<\/p>\n\n\n\n

The aim of the study was to create a system for comprehensive assessment and compensation of the effects of IFIBR- FIBRANIUM products on subjects experiencing pain or discomfort in the lumbar region over a prolonged period of time.<\/p>\n\n\n\n

The aim was achieved by solving the following problems:<\/p>\n\n\n\n

the effects of using \u201cIFIBR \u2013 FIBRANIUM \u201d and placebo products on the functional state of the subjects were investigated;<\/p>\n\n\n\n

a system of diagnostics, analysis and accounting of the dynamics of changes in the functional state of the subjects in a 4-week observation cycle was developed;<\/p>\n\n\n\n

regular dynamic examinations of the subjects during the use of \u201cIFIBR \u2013 FIBRANIUM \u201d products were carried out.<\/p>\n\n\n\n

The developed system of diagnostics of psychophysiological and somatic status of the study participants was based on a set of modern methods of examination, diagnostics and treatment accepted in physiology of labour, in outpatient and clinical medical practice; including research of the state of analysers, immune and hormonal systems, cardiovascular system, hematopoiesis, etc.<\/p>\n\n\n\n

Based on the objectives of the study, methods were used to assess physical performance, functional state of cardiovascular and respiratory systems, vegetative and psychological status, determination of functional reserves of the organism and neurophysiological studies.<\/p>\n\n\n\n

It was shown that when using \u201cIFIBR \u2013 FIBRANIUM \u201d products, there was a distinct decrease in the intensity of pain or unpleasant sensations in the lumbar region, the quality of sleep improved and the psycho-emotional background of the subjects increased.<\/p>\n\n\n\n

In addition to the above mentioned effects, the persons using the \u201cIFIBR \u2013 FIBRANIUM \u201d product also showed correction of metabolic disorders, vegetative-vascular dysfunctions, normalisation of sympatho-adrenal and parasympathetic system reactivity caused by influence on biologically active points.<\/p>\n\n\n\n

When using the product \u201cIFIBR \u2013 FIBRANIUM \u201d there is irritation of skin receptors and, as a result of hypothalamus reaction, smooth muscles of blood vessels are relaxed, as a result of which blood vessels dilate.<\/p>\n\n\n\n

In addition, the product \u201cIFIBR \u2013 FIBRANIUM \u201d has relaxing and sedative effect, promotes wound healing, resorption of haematomas, inhibits the growth of diseased cells. It can be used in weight loss programmes, in the treatment of cellulite (expansion of fat cells and water release), helps to normalise sweating, which facilitates kidney function. With sweat, a large number of toxic substances leave the body.<\/p>\n\n\n\n

It is necessary to emphasise the fact that 77% of the test subjects had a clear therapeutic effect already at 5-10 minutes (!) after using the IFIBR-fibranium mattress pad, which is an undoubted scientific and technological breakthrough.<\/p>\n\n\n\n

The innovative product \u201cIFIBR \u2013 FIBRANIUM \u201d mattress pad is a new and very significant word in the industry of healthy sleep, treatment and prevention of chronic lumbar pain and anti-aging therapy, is an invention that has no analogues.<\/p>\n\n\n\n

Literature<\/strong><\/p>\n\n\n\n

    \n
  1. Kuzyukova A.A. Panic attacks in neurological practice \/ A.A. Ku-zyukova, A.P. Rachin \/\/ RMZh. \u2013 2017. \u2013 \u211613. \u2013 \u0421. 986-99<\/li>\n\n\n\n
  2. Levin, O.S. From vegetative crises to panic attacks\u2026 and back? \/ O.S. Levin \/\/ Modern therapy in psychiatry and neurology. \u2013 2018. \u2013 \u2116 2. \u2013 \u0421. 4 \u2013 1<\/li>\n\n\n\n
  3. Katon W. Panic disorder: relationship to high medical utilisation, unexplained physical symptoms, and medical costs \/ W. Katon \/\/ J Clin Psychiatry. Katon \/\/ J Clin Psychiatry. \u2013 1996. \u2013 N. 57. -P. 11-18<\/li>\n\n\n\n
  4. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication \/ RC Kessler [et al.] \/\/ Archives of General Psychiatry. \u2013 2005. \u2013 Vol. 62, N. 6. \u2013 P. 593-602.<\/li>\n\n\n\n
  5. Podchufarova, E.V. Myogenic back pain: causes of development and methods of treatment \/ E.V. Podchufarova \/\/ RMZh. \u2013 2011. \u2013 \u211630. \u2013 C. 1909.<\/li>\n\n\n\n
  6. Ley R. Blood, breath, and fears: A hyperventilation theory of panic attacks and agoraphobia \/ R. Ley \/\/ Clinical Psychology Review. \u2013 1985. \u2013 Vol. 5. \u2013 P. 271-285<\/li>\n\n\n\n
  7. Bonn J.A. Enhanced adaptive behavioural response in agrophobic patients pre-treated with breathing retraining \/ J.A. Bonn, C.P. Readhead, B.H. Timmons \/\/ The Lancet. \u2013 1984. \u2013 Vol. 324, N. 8404. \u2013 P. 665-669.<\/li>\n\n\n\n
  8. Vein A.M. Neurogenic hyperventilation \/ A.M. Vein, I.V. Moldovanu. -Kishenev: Shtiyintsa, 1988. \u2013 188 \u0441<\/li>\n\n\n\n
  9. Yakupov, E.Z. State of integrative systems of the brain in the syndrome of vegetative dysfunction: autoref. disc. \u2026. Dr. of medical sciences: 14.01.11 \/ Yakupov Eduard Zakirzyanovich. \u2013 Kazan, 2006. \u2013 25\u0441.<\/li>\n\n\n\n
  10. Bighelli I. Is the efficacy of antidepressants in panic disorder mediated by adverse events? [Electronic resource] \/ I. Bighelli, A. Borghesani, C. Barbui \/\/ Plos ONE. \u2013 2017. \u2013 Vol. 1, N. 6. \u2013 Access mode: http:\/\/journals.plos.org\/plosone\/arti-cle?id=10.1371\/journal.pone.0178617<\/li>\n\n\n\n
  11. Craske MG. Anxiety \/ MG. Craske, MB. Stein \/\/ Lancet. \u2013 2016. \u2013 \u2116 388. \u2013 P. 3048-3059.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Dr. Lorusso Rossi Alessandro, PhD (Reading) , (IUHAC Paris, California University USA) Keywords: chronic low back pain, placebo-control, randomised clinical trial, natural minerals, siliconised fibre,<\/p>\n","protected":false},"author":1,"featured_media":242,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-239","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biology-medicine","three-columns"],"_links":{"self":[{"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/posts\/239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=239"}],"version-history":[{"count":1,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/posts\/239\/revisions"}],"predecessor-version":[{"id":241,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/posts\/239\/revisions\/241"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=\/wp\/v2\/media\/242"}],"wp:attachment":[{"href":"http:\/\/worldscientists.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=239"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/worldscientists.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}